Going home from the hospital with a new medicine can be overwhelming. CABLIVI Patient Solutions is here with patient assistance to help you during this transition.
Sanofi reserves the right to modify or terminate these programs at any time without notice.
The Therapeutic Education Managers (TEMs) team is here to provide you with education and answer questions you may have to help you navigate your experience with aTTP. TEMs enhance your knowledge about aTTP so you can have a more empowering conversation with your doctor. Contact CABLIVI Patient Solutions to learn more.
TEMs are paid to provide educational services on behalf of Sanofi Genzyme. They don’t provide medical advice. You should always talk to your doctor about any healthcare needs.
Learn more about the support offered through CABLIVI Patient Solutions.Download
Enroll in CABLIVI Patient Solutions for specialty pharmacy services, administration training, financial assistance, and more.Download
Do not take CABLIVI if you’ve had an allergic reaction to caplacizumab-yhdp or to any of the ingredients in CABLIVI.
Tell your doctor if you have a medical condition including if you have a bleeding disorder. Tell your doctor about any medicines you take.
Talk to your doctor before scheduling any surgery, medical or dental procedure.
CABLIVI can cause severe bleeding. In clinical studies, severe bleeding adverse reactions of nosebleed, bleeding from the gums, bleeding in the stomach or intestines, and bleeding from the uterus were each reported in 1% of subjects.
Contact your doctor immediately if excessive bleeding or bruising occur.
You may have a higher risk of bleeding if you have a bleeding disorder (i.e. hemophilia) or if you take other medicines that increase your risk of bleeding such as anti-coagulants. CABLIVI should be stopped for 7 days before surgery or any medical or dental procedure. Talk to your doctor before you stop taking CABLIVI.
The most common side effects include nosebleed, headache and bleeding gums.
Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of CABLIVI. Call your doctor for medical advice about side effects.
CABLIVI (caplacizumab-yhdp) is a prescription medicine used for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.